<i>N</i>-Phenyl-1-(phenylsulfonyl)-1<i>H</i>-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor
Thomas R. Lane(Collaborations Pharmaceuticals (United States)), Sean Ekins(Collaborations Pharmaceuticals (United States))
Cited by 11
Related Papers
<i>In silico</i> pharmacology for drug discovery: methods for virtual ligand screening and profiling
|British Journal of Pharmacology|2007|693
Antiviral Evaluation of Dispirotripiperazines against Hepatitis B Virus
|Journal of Medicinal Chemistry|2023|9